Group One Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,001
| Closed | -$2.64K | – | 7588 |
|
|
2024
Q2 | $2.64K | Buy |
+4,001
| New | +$2.49K | ﹤0.01% | 6149 |
|
|
2023
Q3 | – | Sell |
-2,473
| Closed | -$3.03K | – | 8483 |
|
|
2023
Q2 | $8.14K | Sell |
2,473
-2
| -0.1% | -$6 | ﹤0.01% | 6493 |
|
|
2023
Q1 | $22.5K | Sell |
2,475
-926
| -27% | -$13.1K | ﹤0.01% | 5424 |
|
|
2022
Q4 | $39.9K | Buy |
3,401
+343
| +11% | +$6.05K | ﹤0.01% | 5168 |
|
|
2022
Q3 | $65K | Buy |
3,058
+827
| +37% | +$22.3K | ﹤0.01% | 5190 |
|
|
2022
Q2 | $54K | Sell |
2,231
-1,056
| -32% | -$35.9K | ﹤0.01% | 5495 |
|
|
2022
Q1 | $164K | Sell |
3,287
-8,177
| -71% | -$404K | ﹤0.01% | 5013 |
|
|
2021
Q4 | $805K | Buy |
11,464
+3,336
| +41% | +$281K | ﹤0.01% | 3579 |
|
|
2021
Q3 | $758K | Buy |
8,128
+6,346
| +356% | +$603K | ﹤0.01% | 3717 |
|
|
2021
Q2 | $179K | Sell |
1,782
-426
| -19% | -$41.5K | ﹤0.01% | 5353 |
|
|
2021
Q1 | $206K | Buy |
+2,208
| New | +$224K | ﹤0.01% | 4997 |
|
|
2020
Q4 | – | Sell |
-1,698
| Closed | -$145K | – | 7125 |
|
|
2020
Q3 | $146K | Buy |
+1,698
| New | +$198K | ﹤0.01% | 3901 |
|
|
2019
Q3 | – | Sell |
-17
| Closed | -$1K | – | 5665 |
|
|
2019
Q2 | $1K | Buy |
+17
| New | +$922 | ﹤0.01% | 4847 |
|
Group One Trading's VBIV Position: Q3 2024 in Review
Group One Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 4,001 shares — an estimated $2.64K sold.
Group One Trading first reported a position in VBIV in Q2 2019 and held it in 13 quarters. The position peaked at $805K in Q4 2021. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Group One Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Group One Trading sold 4,001 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $2.64K.
- Group One Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2019 and held it in 13 quarters.
- Group One Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $805K in Q4 2021.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.